Matt Sinclair 🍉
LightNews LightNews
banner
mattsinclairvo.bsky.social
Matt Sinclair 🍉
@mattsinclairvo.bsky.social
1.8K followers 1.3K following 850 posts
Anime and Video game voice over recording artist, game journalist, and occasional twitch streamer! Remote ready. #Chainsawman #VinnlandSaga #NingenFushin #RWBY #DunkLords Pronouns "she/him/they"

Website: https://mattsinclair.carrd.co/
Posts Replies Media Videos
Reposted by Matt Sinclair 🍉
sailorrooscout.bsky.social
According to the study’s authors, COVID vaccination was effective in all ALL groups and in persons with OR without major chronic conditions.

The study has been published in the New England Journal of Medicine. YES, it is PEER-REVIEWED.
• www.nejm.org/doi/full/10....

🧪🧵⬇️
Abstract BACKGROUND Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, contemporary evidence on vaccine effectiveness against clinically relevant outcomes is needed. METHODS We conducted an observational study that used the electronic health records of the Department of Veterans Affairs to evaluate the effectiveness of the 2024-2025 Covid-19 vaccine among veterans who received the Covid-19 and influenza vaccines on the same day (164,132 participants) and in an active-comparator group of veterans who received the influenza vaccine only (131,839 participants), between September 3 and December 31, 2024. Participants were followed for 180 days or until the occurrence of an outcome, whichever came first. We used inverse-probability-weighted models to estimate vaccine effectiveness (calculated as 1 minus the risk ratio) against Covid-19-associated emergency department visits, hospitalizations, and deaths at 6 months. RESULTS At 6 months of follow-up, the estimated vaccine effectiveness was 29.3% (95% confidence interval [CI], 19.1 to 39.2) against Covid-19-associated emergency department visits (risk difference per 10,000 persons, 18.3; 95% CI, 10.8 to 27.6), 39.2% (95% Cl, 21.6 to 54.5) against Covid-19-associated hospitalizations (risk difference per 10,000 persons, 7.5; 95% Cl, 3.4 to 13.0), and 64.0% (95% CI, 23.0 to 85.8) against Covid-19-associated deaths (risk difference per 10,000 persons, 2.2; 95% Cl, 0.5 to 6.9). Vaccine effectiveness against a composite of these outcomes was 28.3% (95% CI, 18.2 to 38.2), with a risk difference per 10,000 persons of 18.2 (95% Cl, 10.7 to 27.5). The Covid-19 vaccine was associated with decreased risks of these outcomes across prespecified subgroups defined according to age (<65 years, 65 to 75 years, and >75 years), the presence or absence of major coexisting conditions, and immunocompetence status. CONCLUSIONS In this national cohort of U.S. veterans, the receipt of the 2024-2025 Covid-19 vaccine was associated with decreased risks of severe clinical outcomes. (Funded by the Department of Veterans Affairs.)
November 7, 2025 at 5:02 PM
Reposted by Matt Sinclair 🍉
bookwormywriter.bsky.social
Still looking for $50 after my dehydration scare and hospital visit; also $45 for ambulance ride. Anything helps.

ko-fi.com/bookwormywri...

#mutualaidrequest #helpfolkslive2025 #mutualaid #helpsky 💸💕
Support Bookworm
Support Bookworm
ko-fi.com
September 29, 2025 at 3:26 PM
Reposted by Matt Sinclair 🍉
katmabu.bsky.social
But we know their playbook now. And we can fight it.

I want to get into Congress, partly to establish laws that limit crooked campaign spending like AIPAC’s. But to do that, we’ve gotta win.

Help us beat AIPAC here: secure.actblue.com/donate/abu-b...
Chip in to support Kat Abughazaleh!
Show your support with a contribution.
secure.actblue.com
September 30, 2025 at 12:27 AM